Business Targets
Visit Targets
49 source-backed visit targets across the Hong Kong / Shenzhen corridor and Greater Bay Area. Contact routes stay in your private pack.
XtalPi晶泰科技
Shenzhen-founded, HK-listed quantum-physics-plus-AI drug discovery platform serving most of global big pharma — the Shenzhen counterpart to Insilico for AI-native discovery, and a strong platform-benchmarking peer.
BGI Genomics (GeneT / GBI ALL)华大基因（GeneT / 生成式生物智能）
Shenzhen-headquartered genomics giant whose GeneT (Genetic Transformer) multimodal genomic foundation model anchors its 'Generative Bio-Intelligence (GBI ALL)' paradigm — and which already runs a large AI-genomics operation inside Saudi Arabia (Genalive, Riyadh), making it the most Saudi-relevant company in this AI-biotech batch.
Xbiome未知君
Shenzhen clinical-stage, AI-driven microbiome drug developer that also does consumer-facing functional probiotics and strain licensing — the most credible China microbiome bridge to a consumer-health brand like Coolvex.
iCarbonX碳云智能
Shenzhen 'digital life' company building an AI platform that fuses multi-omics (genome, metabolome, microbiome) with lifestyle data to model individual health — an early, ambitious AI-multi-omics play whose mid-2010s hype has cooled and whose current momentum is unclear.
MegaRobo镁伽
A Beijing-headquartered embodied-AI-for-the-lab company fusing robotics automation and AI to build intelligent, self-running biological laboratories (MEGALAB) — the infrastructure layer under AI drug discovery, synthetic biology and bioprocess; included as a benchmark/ecosystem reference, with HQ in Beijing rather than the GBA.